Blogs
Healthcare and Medtech Research Reports
Nov 05, 2018
It is said old is gold. True indeed! As a case in point, a 150-year-old drug has gained prominence as a potential cancer therapy in the future to bring in much relief to cancer patients. Recently, researchers from the Ohio State University in the USA have found that the drug called Papaverine could make tumours more...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper